Is there any evidence that GLP-1 use in adolescents has adverse mental health outcomes?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

There is limited evidence on the adverse mental health outcomes of GLP-1 receptor agonists in adolescents, and further study is needed to understand potential risks in this population.

Fields of Study & Subjects

Diabetes Treatment and Management Pharmacology and Obesity Treatment Diabetes Management and Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 March 2026
Language
EN